Alessandro Picelli Selected Research

Type A Botulinum Toxins (Botox)

6/2021	Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity.
1/2021	Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study.
1/2021	Electrical Stimulation of Injected Muscles to Boost Botulinum Toxin Effect on Spasticity: Rationale, Systematic Review and State of the Art.
12/2020	Does Botulinum Toxin Treatment Affect the Ultrasonographic Characteristics of Post-Stroke Spastic Equinus? A Retrospective Pilot Study.
6/2020	Diagnostic nerve block in prediction of outcome of botulinum toxin treatment for spastic equinovarus foot after stroke: A retrospective observational study.
1/2020	Combined effects of backward treadmill training and botulinum toxin type A therapy on gait and balance in patients with chronic stroke: A pilot, single-blind, randomized controlled trial.
7/2019	Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
2/2019	Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
1/2019	Effectiveness of Robot-Assisted Upper Limb Training on Spasticity, Function and Muscle Activity in Chronic Stroke Patients Treated With Botulinum Toxin: A Randomized Single-Blinded Controlled Trial.
1/2019	Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Picelli Research Topics

Disease

42	Stroke (Strokes) 01/2022 - 06/2011
22	Muscle Spasticity (Spastic) 03/2022 - 05/2012
11	Pain (Aches) 06/2022 - 08/2015
6	Parkinson Disease (Parkinson's Disease) 07/2021 - 03/2014
5	Clubfoot (Talipes Equinovarus) 03/2022 - 11/2017
3	Multiple Sclerosis 04/2021 - 10/2015
3	Shoulder Pain 01/2021 - 09/2017
3	Perceptual Disorders (Hemispatial Neglect) 04/2019 - 09/2013
2	Tendinopathy (Tendonitis) 01/2022 - 01/2019
2	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2021 - 01/2014
2	Contracture 01/2021 - 08/2015
2	MELAS Syndrome (Syndrome, MELAS) 01/2020 - 01/2019
2	Cerebral Palsy (Spastic Diplegia) 07/2019 - 04/2017
2	Headache (Headaches) 02/2018 - 12/2016
1	Musculoskeletal Pain 06/2022
1	Fibromyalgia (Fibrositis) 06/2022
1	Hemorrhagic Stroke 01/2022
1	Cognitive Dysfunction 07/2021
1	COVID-19 06/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Wrist Fractures 08/2020
1	Paresis (Hemiparesis) 01/2019
1	Anterior Cruciate Ligament Injuries 12/2018
1	Radiculopathy (Radiculopathy, Cervical) 10/2018
1	Trigeminal Neuralgia (Tic Douloureux) 10/2018
1	Neuralgia (Stump Neuralgia) 10/2018
1	Migraine Disorders (Migraine) 02/2018
1	Chronic Pain 09/2017
1	Low Back Pain (Lumbago) 12/2016
1	Tremor (Tremors) 01/2016
1	Dyskinesias (Dyskinesia) 01/2016
1	Hypokinesia (Bradykinesia) 01/2016
1	Fatigue 10/2015
1	Piriformis Muscle Syndrome 08/2015
1	Muscle Hypertonia 08/2015
1	Brain Injuries (Brain Injury) 01/2014
1	Craniocerebral Trauma (Head Injury) 01/2014
1	Nervous System Diseases (Neurological Disorders) 10/2013
1	Dystonia (Limb Dystonia) 10/2013
1	Scoliosis 01/2008

Drug/Important Bio-Agent (IBA)

23	Type A Botulinum Toxins (Botox)FDA Link 06/2021 - 05/2012
14	Botulinum Toxins (Botulinum Toxin)IBA 06/2021 - 07/2012
12	incobotulinumtoxinA FDA Link 06/2021 - 07/2012
3	abobotulinumtoxinA FDA Link 12/2020 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	salicylhydroxamic acid (SHAM)IBA 04/2019 - 01/2015
2	Pharmaceutical PreparationsIBA 10/2018 - 01/2016
2	Analgesics (Analgesic Drugs)IBA 10/2018 - 02/2018
1	Vitamin D FDA LinkGeneric 06/2022
1	Deep-HeatIBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	Biological ProductsIBA 01/2020
1	Phenol (Carbolic Acid)FDA Link 02/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 10/2018
1	amsonic acid (DAS)IBA 01/2018
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 09/2017
1	Methylprednisolone FDA LinkGeneric 09/2017
1	brain-derived growth factorIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2016
1	Substance PIBA 08/2015
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2014
1	onabotulinum toxin AIBA 01/2014

Therapy/Procedure

12	Therapeutics 01/2022 - 12/2014
7	Injections 01/2021 - 05/2012
6	Nerve Block (Nerve Blocks) 03/2022 - 09/2017
6	Neurological Rehabilitation 02/2021 - 10/2013
5	Transcranial Direct Current Stimulation 01/2021 - 06/2011
4	Aftercare (After-Treatment) 09/2021 - 10/2015
4	Extracorporeal Shockwave Therapy 07/2019 - 01/2014
3	Stroke Rehabilitation 06/2021 - 09/2013
2	Diathermy 01/2022 - 09/2021
2	Resistance Training 01/2020 - 01/2019
2	Physical Therapy Modalities (Physical Therapy Technique) 07/2019 - 12/2016
1	Cognitive Training 07/2021
1	Activities of Daily Living (ADL) 01/2021
1	Secondary Prevention 12/2018
1	Pulsed Radiofrequency Treatment 01/2018
1	Telerehabilitation 01/2017
1	Denervation 01/2016
1	Ultrasonic Therapy 01/2014
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2014
1	Braces 01/2008